对癌症自的表观遗传向:DNA和RNA甲基化
Luobin Lin1, Yuntao Zhao1, Qinzhou Zheng1
1Guangdong Province Key Laboratory of Biotechnology Drug Candidates, School of Life Sciences and Biopharmaceuticals, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
Frontiers in oncology
|December 27, 2023
概括
表观遗传修饰,包括DNA N6 - 甲基脱氧腺 (6mA) 和RNA N6 - 甲基腺 (m6A),显著调节自. 了解这些甲基化标记可以通过调节自来为癌症提供新的治疗策略.
科学领域:
- 细胞生物学 细胞生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子瘤学分子瘤学
背景情况:
- 自是细胞降解和循环的重要细胞过程,在癌症中具有复杂的作用,既起瘤抑制作用,又起瘤促进作用.
- 表观遗传修饰,特别是DNA 6mA和RNA m6A,正在成为细胞过程的关键调节者,包括自.
- 这些甲基化标记和自的相互作用对于理解癌症的发展和进展至关重要.
研究的目的:
- 在自调节的背景下,审查目前对DNA 6mA和RNA m6A甲基化的理解.
- 探索这些表观遗传修饰对癌症自途径的影响.
- 突出针对6mA,m6A和自的潜力,用于新的癌症疗法.
主要方法:
- 对调查DNA 6mA,RNA m6A和癌症自的研究进行文献综述.
- 对将表观遗传修饰与自活动联系起来的分子机制的分析.
- 对针对这些途径的治疗影响进行当前研究的综合.
主要成果:
- DNA 6mA和RNA m6A的修改是复杂的网络中不可或缺的组成部分,它调节了自.
- 这些表观遗传标记影响了参与自道的基因的表达和功能,影响了癌症生物学.
- 6mA和m6A的失调与各种癌症的自流变化有关.
结论:
- DNA 6mA和RNA m6A代表控制自的关键表观遗传层.
- 针对这些甲基化修改,通过调节自,为癌症干预提供了有希望的治疗途径.
- 对6mA-m6A-自轴的进一步研究是开发创新的癌症治疗方法的必要条件.
相关概念视频
01:37Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:27Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:36Delivery Pathways to the Lysosome
6.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.6K
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K